Figure 1.

Inhibitory effects of aqueous extracts from plant seeds on amyloid beta (1–42). Levels of amyloid beta (1–42) in mixtures (10 μM amyloid beta (1–42) 55 μL and aqueous extracts from plant seeds 55 μL) were determined with human enzyme-linked immunosorbent assay. The mixtures (110 μL) were incubated at room temperature for 24 h. After incubation, amyloid beta (1–42) was analyzed. The A450 nm of amyloid beta (1–42) treatment and amyloid beta (1–42) + aqueous extracts from plant seeds treatments are indicated by unshaded and shaded columns, respectively. Data represents the percentage of amyloid beta (1–42) + aqueous extracts from plant seeds treated cells relative to amyloid beta (1–42) treated cells: % Control ratio = (A450 nm of amyloid beta (1–42) + aqueous extracts from plant seeds treated cells/A450 nm of amyloid beta (1–42) treated cells) ×100. Values are the mean ± standard deviation of the three measurements. **P < 0.01, *P < 0.05 compared with the controls